![Nathan Higginson-Scott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nathan Higginson-Scott
Directeur Technique/Scientifique/R&D chez PANDION THERAPEUTICS, INC.
Postes actifs de Nathan Higginson-Scott
Sociétés | Poste | Début | Fin |
---|---|---|---|
PANDION THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2020 | - |
Historique de carrière de Nathan Higginson-Scott
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Pandion Therapeutics, Inc.
![]() Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA. | Health Technology |
- Bourse
- Insiders
- Nathan Higginson-Scott
- Expérience